Background {#Sec1}
==========

Coffee is one of the most widely used beverages worldwide. In the recent decades, there are lots of studies about the relationship of coffee consumption and a series of diseases, such as cardiovascular disease \[[@CR1]\], cerebrovascular disease \[[@CR2]\], insomnia \[[@CR3]\] and diabetes \[[@CR4]\]. Several meta-analyses confirmed that coffee consumption was associated with a lower risk of type 2 diabetes mellitus \[[@CR5]--[@CR7]\]. As we know, insulin resistance and beta cell function deterioration are the two critical underlying traits of diabetes pathogenesis. However, the connection between coffee and diabetes pathogenesis is still controversial. For instance, a Swedish study implied that coffee intake might involve both improved insulin sensitivity and enhanced insulin response \[[@CR8]\]. Nonetheless, some others showed that coffee was associated with insulin sensitivity but not insulin secretion. Arnlov J et al. only found relationship of coffee intake with insulin sensitivity but not with early phase insulin secretion during an oral glucose tolerance test \[[@CR9]\]. Thus, it is still significant to further investigate the relationship between coffee and the pathogenesis of diabetes.

China is a newly coffee consumption country, more and more people custom to having coffee frequently. Meanwhile, China has large diabetes epidemic.The estimated overall prevalence of total diabetes and of pre-diabetes is 10.9 and 35.7%, respectively \[[@CR10]\]. However, the association between coffee consumption and diabetes or the pathogenesis in Chinese population is largely unknown.

In the present study, we aim to evaluate the association of coffee intake and the prevalence of newly diagnosed diabetes as well as diabetic pathogenesis in a large high-risk diabetic Chinese Population from Shanghai High-risk Diabetic Screen project (SHiDS).

Methods {#Sec2}
=======

Study design and population {#Sec3}
---------------------------

The study population was selected from the Shanghai High-Risk Diabetic Screen (SHiDS) project, a large clinic based screening project that was implemented since 2002. Details on the methodology have previously been reported \[[@CR11]\]. In brief, the SHiDS project involves screening of individuals with known risk factors for diabetes. The inclusion criterion of SHiDS study is individuals with at least one of the known risk factors for diabetes including 1) family history of diabetes, 2) being overweight or obese, 3) previously identified impaired fasting glucose or impaired glucose tolerance, 4) history of gestational diabetes, 5) polycystic ovary syndrome, 6) hypertension, 7) dyslipidemia. Previously diagnosed diabetic patients were excluded from the study \[[@CR11]\]. For the present study, a total of 1328 individuals over 18 years of age who have the information of coffee intake were enrolled in the study from 2012 to 2016. This study was approved by the Institutional Review Board of Shanghai JiaoTong University Affiliated Sixth People's Hospital in accordance with the principles of the Helsinki Declaration. Informed consent was obtained from each subject before the survey.

Data collection {#Sec4}
---------------

Participants arrived at the hospital at 7: 30 AM after an 8 h overnight fasting before the five-point 75 g oral glucose tolerance test (OGTT). Each participant underwent a physical examination including measurement of height, weight, waist circumference and blood pressure. Body mass index (BMI) was calculated as weight divided by height squared (kg/m^2^). A standard questionnaire was conducted by trained research staff. Data on the current lifestyle, coffee intake, tea intake, smoking habit, alcohol intake, physical activity, medical record, diabetes family history (first degree relatives only) and educational status were collected for each participant. Venous blood samples were collected at 0, 30, 60, 120 and 180 min during a standard 75 g-OGTT, and plasma glucose levels were measured using a glucose oxidase method. Glycosylated hemoglobin A1c (HbA1c) was measured by high performance liquid chromatography. Glycated albumin (GA) was measured by the liquid enzymatic assay. Serum insulin levels were measured using a chemical luminescence method.

Diabetes was diagnosed according to the standard criteria by the World Health Organization (WHO) in 1999 \[fasting plasma glucose (FPG) ≥7.0 mmol/L or 2-h postprandial plasma glucose (PG2h) ≥11.1 mmol/L\]. Hypertension and dislipidemia were defined as self-reported with a validated history diagnosed by doctors. Insulin resistance was assessed by homeostatic model assessment of insulin resistance (HOMA-IR) value \[[@CR12]\]. Pancreatic beta cell function was evaluated by homeostatic model assessment of β-cell function (HOMA-β) value \[[@CR13]\], Stumvoll first phase and second phase indexes, respectively \[[@CR14]\].

HOMA-IR = fasting serum insulin (FIN) (mU/L) × FPG (mmol/L) / 22.5 \[[@CR12]\]

HOMA-β = 20 × FIN (mU/L) / \[FPG (mmol/L) - 3.5\] \[[@CR13]\]

Stumvoll1st phase = 2503 + 38.856 × FIN (mU/L) - 126.5 × PG2h (mmol/l) + 5.724 × 2-h postprandial serum insulin (IN2h) (mU/L) - 239.3 × FPG (mmol/l) \[[@CR14]\].

Stumvoll 2nd phase = 393 + 6.978 × FIN (mU/L) - 40.72 × PG2h (mmol/l) + 1.878 × IN2h (mU/L) \[[@CR14]\]

Statistical analyses {#Sec5}
--------------------

Statistical analyses were performed using SPSS 20.0 (SPSS, Inc., Chicago, IL). FPG, 30-min postprandial plasma glucose (PG30min), 1-h postprandial plasma glucose (PG1h), PG2h, 3-h postprandial plasma glucose (PG3h), FIN, 30-min postprandial serum insulin (IN30min), 1-h postprandial serum insulin (IN1h), IN2h, 3-h postprandial serum insulin (IN3h), HbA1c, GA and HOMA-IR were logarithmic transformed to obtain approximate normal distribution before statistical analysis. Participant characteristics were tested for differences across coffee intake categories. Variables with approximately normal distribution were presented as means ± standard deviation while those with skew distribution were shown as median \[interquartile range (IQR)\] and classified variable as frequencies and percentages. Continuous variables were compared by t-test while classified variable by chi-square test. The associations of coffee intake with different variables were analyzed by covariance. Logistic regression was used to model associations between coffee consumption and insulin secretion indexes, taking account of potential confounders. All reported *P* values were two-tailed and *P* \< 0.05 were considered statistically significant.

Result {#Sec6}
======

Clinical characteristics of the participants stratified by coffee consumption {#Sec7}
-----------------------------------------------------------------------------

The demographic and clinical characteristics of the participants are presented in Table [1](#Tab1){ref-type="table"}. After statistical analysis by t-test, it showed that coffee consumed population was relatively younger and fatter than non-coffee participants (*P* for age \< 0.001; *P* for BMI \< 0.001; *P* for waist \< 0.001; *P* for fat% = 0.004). Besides, coffee consumed group had higher education level (*P* \<  0.001), current smoke percentage (*P* = 0.010), current alcohol intake percentage (*P* = 0.001), tea consumption percentage (*P* \< 0.001) and higher percentage of diabetes family history (*P* = 0.041). The prevalence of hypertension and dyslipidemia were not different between these two groups.Table 1Clinical characteristics of the participants stratified by coffee consumptionNon-coffee (*n* = 818)Coffee (*n* = 510)Total (*n* = 1328)*P*Male (n, %)330 (40.34%)210 (41.18%)540 (40.66%)0.763Age, years (mean, SD)52.80 (14.22)48.34 (14.49)51.08 (14.47)\<  0.001Weight, kg (mean, SD)65.07 (12.60)69.99 (14.24)66.95 (13.46)\<  0.001BMI, kg/m^2^ (mean, SD)23.96 (3.65)25.18 (4.08)24.43 (3.87)\<  0.001Waist, cm (mean, SD)86.46 (10.19)88.79 (11.07)87.35 (10.59)\<  0.001Fat, % (mean, SD)28.37 (7.70)29.81 (8.25)28.91 (7.94)0.004SBP, mmHg (mean, SD)130.39 (18.17)130.23 (17.41)130.33 (17.88)0.880DBP, mmHg (mean, SD)79.02 (10.93)79.20 (11.33)79.09 (11.09)0.776Diabetic family history (n, %)351 (44.94%)249 (50.82%)1271 (47.21%)0.041Hypertension (n, %)279 (34.15%)160 (31.37%)1327 (33.08%)0.296Dislipidemia (n, %)249 (30.48%)168 (33.01%)1326 (31.45%)0.335Higher Education (n, %)370 (45.23%)312 (61.18%)1328 (51.36%)\<  0.001Current smoke (n, %)104 (12.73%)91 (17.88%)1326 (14.71%)0.010Current alcohol intake (n, %)115/703 (14.06%)107/402 (21.02%)222 (16.73%)0.001Tea consumption (n, %)293 (35.91%)321 (62.94%)1326 (46.30%)\<  0.001Frequent physical activity (n, %)629 (76.99%)385 (75.49%)1327 (76.41%)0.532FPG, mmol/L (median, IQR)6.15 (5.46--7.06)6.04 (5.36--7.14)6.11 (5.42--7.08)0.259PG30min, mmol/L (median, IQR)10.67 (9.09--12.38)10.47 (9.05--12.27)10.60 (9.07--12.35)0.188PG1h, mmol/L (median, IQR)12.29 (9.79--15.25)12.19 (9.43--14.97)12.25 (9.68--15.14)0.148PG2h, mmol/L (median, IQR)10.02 (7.36--14.31)9.53 (7.09--13.47)9.85 (7.28--14.06)0.024PG3h, mmol/L (median, IQR)6.69 (4.84--9.62)6.30 (4.55--8.97)6.45 (4.74--9.35)0.016FIN, uIU/mL (median, IQR)8.43 (5.75--12.61)10.10 (6.94--16.22)9.08 (6.02--13.81)\<  0.001IN30min, uIU/mL (median, IQR)44.05 (27.52--69.97)58.09 (34.50--93.70)48.21 (28.82--80.23)\<  0.001IN1h, uIU/mL (median, IQR)64.58 (40.18--101.45)77.03 (50.30--121.83)69.20 (44.25--107.50)\<  0.001IN2h, uIU/mL (median, IQR)69.91 (45.83--115.70)81.54 (51.53--128.38)74.75 (48.05--119.05)0.002IN3h, uIU/mL (median, IQR)32.22 (17.34--57.65)34.29 (18.23--62.04)32.75 (17.64--58.38)0.237HbA1c, % (median, IQR)6.00 (5.60--6.50)5.90 (5.50--6.60)5.90 (5.60--6.50)0.855GA, % (median, IQR)14.30 (12.80--16.60)13.85 (12.40--16.70)14.10 (12.70--16.68)0.263Newly diagnosed diabetes (n, %)381 (46.58%)213 (41.76%)594 (44.73%)0.037Impaired glucose regulation (n, %)237 (28.97%)148 (29.02%)385 (28.99%)0.241HOMA-β (mean, SD)84.30 (89.77)104.65 (103.29)92.11 (95.66)\<  0.001HOMA-IR (median, IQR)2.37 (1.49--3.71)2.80 (1.75--4.61)2.52 (1.60--4.04)\<  0.001Stumvoll first phase (mean, SD)459.97 (1096.52)717.67 (1060.32)558.85 (1089.60)\<  0.001Stumvoll second phase (mean, SD)179.32 (248.52)242.04 (246.55)203.33 (249.54)\<  0.001Continuous variables were compared by t-test while classified variable by chi-square testVariables with approximately normal distribution were presented as means ± standard deviation while those with skew distribution were shown as median (inter quartile range) and classified variable as frequencies and percentagesAbbreviations: *SD* standard deviation, *IQR* inter quartile range, *BMI* body mass index, *SBP* systolic pressure, *DBP* diastolic pressure, *FPG* fasting plasma glucose, *PG30min* 30-min postprandial plasma glucose, *PG1h* 1-h postprandial plasma glucose, *PG2h* 2-h postprandial plasma glucose, *PG3h* 3-h postprandial plasma glucose, *HbA1c* glycosylated hemoglobin A1c, *GA* glycated albumin, *FIN* fasting serum insulin, *IN30min* 30-min postprandial serum insulin, *IN1h* 1-h postprandial serum insulin, *IN2h* 2-h postprandial serum insulin, *IN3h* 3-h postprandial serum insulin, *HOMA-IR* homeostatic model assessment of insulin resistance, HOMA-β, homeostatic model assessment of β-cell function

In terms of glucose metabolism, the coffee intake group had lower 2-h and 3-h plasma glucose levels during OGTT (*P* for PG2h = 0.024; *P* for PG3h = 0.016). However, the plasma glucose levels at fasting, 30-min, 1-h were not different between these two populations, so as the HbA1c level and GA level. According to the chi-square test, coffee intake group had lower prevalence of newly diagnosed diabetes (*P* = 0.037).

In terms of insulin levels, coffee consumption group had higher insulin levels at fasting, 30-min, 1-h and 2-h during OGTT (*P* for FIN \< 0.001; *P* for IN30min \< 0.001; *P* for IN1h \< 0.001; *P* for IN2h = 0.002), but serum insulin level at 3-h was not different from the non-coffee intake group. Pancreatic beta cell function and insulin resistance were further estimated by HOMA and Stumvoll indexes. It implied that coffee intake individuals had higher insulin secretion level (*P* for HOMA-β \< 0.001; *P* for Stumvoll first phase \< 0.001; *P* for Stumvoll second phase \< 0.001) and lower insulin sensitivity (*P* for HOMA-IR \< 0.001).

Coffee consumption and glucose metabolism, insulin secretion and insulin sensitivity {#Sec8}
------------------------------------------------------------------------------------

The relationships of coffee intake and glucose metabolism, insulin secretion and insulin sensitivity were further analyzed by different adjusted models (Table [2](#Tab2){ref-type="table"}). First of all, coffee consumption group had lower plasma glucose levels at 2-h and 3-h and higher insulin levels at fasting, 30-min and 1-h during OGTT after adjustment with age, fat%, BMI, waist, tea intake, smoking habit, alcohol intake, diabetes family history and educational status (*P* for PG2h = 0.002; *P* for PG3h = 0.010; *P* for FIN = 0.010; *P* for IN30min = 0.001; *P* for IN1h = 0.002). Nevertheless, the difference of the prevalence of newly diagnosed diabetes between these two groups was not significant after adjusted with age (*P* = 0.718). Secondly, a relatively strong association was found between coffee consumption and insulin secretion after adjusted with variety confounders mentioned above that might interfere with the relationship of coffee intake and pancreatic beta cell function. Both HOMA-β and Stumvoll formula indexes were positively related to coffee consumption (*P* for HOMA-β = 0.033; *P* for Stumvoll first phase = 0.003; *P* for Stumvoll second phase = 0.001). However, insulin sensitivity index was not statistically different between coffee consumed population and non-coffee consumed population after adjustment.Table 2Adjusted Mean (SD) values for metabolic measures according to the relationship with coffee consumptionlgPG2hlgPG3hNon-coffeeCoffee*P*\*Non-coffeeCoffee*P*\*Model 11.01 ± 0.180.98 ± 0.190.477Model 10.84 ± 0.210.81 ± 0.210.122Model 21.01 ± 0.180.99 ± 0.190.020Model 20.85 ± 0.210.82 ± 0.210.021Model 31.02 ± 0.180.99 ± 0.190.002Model 30.85 ± 0.210.82 ± 0.210.010lgFINlgIN30minNon-coffeeCoffee*P*\*Non-coffeeCoffee*P*\*Model 10.92 ± 0.291.01 ± 0.29\< 0.001Model 11.64 ± 0.341.74 ± 0.36\< 0.001Model 20.92 ± 0.301.01 ± 0.290.012Model 21.64 ± 0.341.75 ± 0.350.002Model 30.92 ± 0.291.01 ± 0.290.010Model 31.64 ± 0.341.74 ± 0.350.001lgIN1hlgIN2hNon-coffeeCoffee*P*\*Non-coffeeCoffee*P*\*Model 11.80 ± 0.311.87 ± 0.32\< 0.001Model 11.85 ± 0.311.90 ± 0.310.004Model 21.79 ± 0.301.87 ± 0.310.014Model 21.85 ± 0.311.90 ± 0.300.287Model 31.79 ± 0.301.87 ± 0.310.002Model 31.85 ± 0.311.90 ± 0.300.120lgHOMA-IRHOMA-βNon-coffeeCoffee*P*\*Non-coffeeCoffee*P*\*Model 10.37 ± 0.320.44 ± 0.33\< 0.001Model 184.30 ± 89.77104.65 ± 103.290.025Model 20.37 ± 0.330.45 ± 0.320.053Model 280.59 ± 85.37104.70 ± 96.930.090Model 30.37 ± 0.320.45 ± 0.320.085Model 378.06 ± 70.6199.44 ± 74.480.033Stumvoll first phaseStumvoll second phaseNon-coffeeCoffee*P*\*Non-coffeeCoffee*P*\*Model 1459.97 ± 1096.52717.67 ± 1060.320.005Model 1179.32 ± 248.52242.04 ± 246.550.002Model 2415.95 ± 1102.94681.45 ± 1041.090.045Model 2170.08 ± 249.30236.52 ± 236.910.020Model 3392.53 ± 1101.89659.70 ± 1029.830.003Model 3166.15 ± 249.01232.98 ± 233.960.001Values presented as Mean ± SD. PG2h, PG3h, FIN, IN30min, IN1h, IN2h and HOMA-IR were logarithmic transformed\**P*-value for the test of any association between coffee consumption and the outcome of interestModel 1: adjusted for ageModel 2: Model 1 + BMI, Fat%, WaistModel 3: Model 2 + education status, smoke status, alcohol intake, tea consumption, diabetes family historyAbbreviations: *SD* standard deviation, *BMI* body mass index, *PG2h* 2-h postprandial plasma glucose, *PG3h* 3-h postprandial plasma glucose, *FIN* fasting serum insulin, *IN30min* 30-min postprandial serum insulin, *IN1h* 1-h postprandial serum insulin, *IN2h* 2-h postprandial serum insulin, *HOMA-IR* homeostatic model assessment of insulin resistance, *HOMA-β* homeostatic model assessment of β-cell function

Logistic regression analysis about the relationship of insulin secretion and coffee consumption {#Sec9}
-----------------------------------------------------------------------------------------------

Logistic regression was conducted to further analysis the relationship of coffee intake and insulin secretion (Table [3](#Tab3){ref-type="table"}). Insulin secretion indexes were expressed in quartiles and were taken as dependent variable. Coffee intake and the other parameters (age, gender distribution, BMI, fat%, waist, education status, smoke status, alcohol intake, tea consumption, diabetes family history) were taken as independent variables. It showed that coffee consumption was significantly and positively associated with insulin secretion. After adjusted with the confounders (model 1, model 2 and model 3), Logistic regression analysis further confirmed that coffee consumers had higher levels of HOMA-β and Stumvoll insulin secretion indexes {model 3: odds ratio (OR) \[95% confidence interval (CI)\] for HOMA-β = 2.262 (1.451--3.527); OR (95% CI) for Stumvoll first phase = 2.041 (1.331--3.131); OR (95% CI) for Stumvoll second phase = 1.890 (1.243--2.874)}. Thus, participant consumed coffee might have better insulin secretion function, including the basic insulin secretion and the two phases of insulin secretion during OGTT.Table 3Odds ratios (95% CI) for the association between coffee consumption and insulin secretion indexesHOMA-β (the highest quartiles)coffee consumptionOR95% CI*P*\* Model 12.2401.598--3.140\< 0.001 Model 22.0481.359--3.0860.001 Model 32.2621.451--3.527\< 0.001Stumvoll first phase (the highest quartiles)coffee consumptionOR95% CI*P*\* Model 11.8181.297--2.5490.001 Model 21.8071.222--2.6720.003 Model 32.0411.331--3.1310.001Stumvoll second phase (the highest quartiles)coffee consumptionOR95% CI*P*\* Model 11.7301.238--2.4190.001 Model 21.7621.196--2.5950.004 Model 31.8901.243--2.8740.003\**P*-value for the test of any association between coffee consumption and the outcome of interestModel 1: adjusted for age, gender distributionModel 2: Model 1 + BMI, Fat%, WaistModel 3: Model 2 + education status, smoke status, alcohol intake, tea consumption, diabetes family history

Discussion {#Sec10}
==========

As far as we know, the present study was the first investigation about relationship between coffee intake and diabetes as well as its pathogenesis in a large high-risk diabetic Chinese population. It showed that coffee intake was positively associated with fasting and the first hour insulin levels and inversely associated with second and third hour plasma glucose levels during the OGTT. In addition, Logistic analysis revealed that coffee consumption was independently and positively related to a series of insulin secretion indexes, including HOMA-β, Stumvoll first and second phase insulin secretion indexes. The HOMA calculation is derived from a computer solved model that assumes relationships between fasting plasma glucose and insulin concentration \[[@CR13]\]. HOMA-β evaluated the basic insulin secretion function \[[@CR15]\]. Stumvoll 1st and 2nd phase insulin secretion indexes are simple demographic parameters and they can evaluate insulin release accuracy \[[@CR16]\]. The significance of the first phase insulin secretion might reflect the existence of a compartment of readily releasable insulin within the beta cell or a transientrise and fall of a metabolic signal for insulin secretion \[[@CR17], [@CR18]\]. The second phase of insulin secretion is directly related to the level of glucose elevation \[[@CR18]\]. Thus, the present study implied that coffee consumers not only had better basal pancreatic beta cell function, but also had superior postprandial beta cell function.

Our findings were consistent with some previous investigations. The results from Agardh et al. showed that in those with type 2 diabetes high coffee consumption was inversely associated with decreased beta cell function which was evaluated by HOMA-β \[[@CR8]\]. It suggested an effect of coffee on beta-cell function and there was a tendency of improved insulin response in those with high coffee consumption \[[@CR8]\]. The results from Wu TY et al. provided support for the potential benefit of chronic coffee consumption on insulin secretion and possibly diabetes \[[@CR19], [@CR20]\]. However, there are some inconsistencies in the effect of coffee on insulin secretion. In a cross-sectional analysis of Japanese population, higher coffee consumption was not associated with insulin secretion, as evaluated through the HOMA \[[@CR21]\]. Another cross-sectional study from the Uppsala Longitudinal Study of Adult Men showed that there was no association between coffee consumption and early insulin response during an OGTT \[[@CR9]\]. The differences in race and population selection criteria might cause different results of relationship between coffee intake and insulin secretion.

The mechanisms that coffee may have beneficial effects on pancreatic beta cell function are still unclear. Coffee contains a lot of components. Caffeine is the major one which is already known to enhance insulin secretion \[[@CR8], [@CR22]\]. It has been proved that insulin concentration tended to be higher in the first 30 min after caffeinated coffee consumption compared with that of decaffeinated coffee or water \[[@CR23]\]. Another study revealed that insulin was significantly higher after caffeine coffee than after water during the first hour of the OGTT \[[@CR24]\]. Other major components of coffee including magnesium, chlorogenic acid and various other micronutrients could also be involved in insulin secretion \[[@CR25]\]. Chlorogenic acid is another major ingredient in coffee. There is evidence that chlorogenic acid might stimulate glucagon-like peptide 1 (GLP-1) production which is one of the gastrointestinal hormones and is known to have an effect on beta cell function that amplifies glucose-dependent insulin secretion \[[@CR23], [@CR26]\]. On the other hand, magnesium has also been shown to improve β-cell function. Previous study found that increase in erythrocyte magnesium significantly and positively correlated with the increase in both insulin secretion and action \[[@CR27]\]. Thus, more and deeper investigations are necessary to reveal the mechanisms that coffee is benefit for insulin secretion and glucose homeostasis.

There are some strengths of our study. First of all, each diabetic patient was newly diagnosed by astandard 75 g-OGTT. Thus, the effect of anti-diabetic medication on the relationship of coffee intake and hyperglycemia can be excluded. We also tested the 5-point blood glucose and insulin levels during the OGTT, which made it possible for us to entirely investigate the dynamic fluctuations in insulin secretion after glucose load. Secondly, to our knowledge, there were few studies on coffee intake and hyperglycemia in Chinese population. The population of China accounts for one fifth of the world's population and China is becoming an emerging coffee consumer country. According to the 2017--2021 China coffee industry development prospect forecast and investment analysis report, coffee consumption is growing by 15 to 20% a year in China \[[@CR28]\]. Thus, it is especially important to evaluate the relationship of coffee intake with glucose metabolism in Chinese population. Our study extended the apparent protective effect of coffee on insulin secretion and glucose metabolism.

Except for the major results of the present study, we also found that coffee consumed group had higher current smoke percentage, current alcohol intake percentage and tea consumption percentage. These results were consistent with the previous studies \[[@CR8], [@CR19], [@CR25], [@CR29]\]. It is well-known that alcohol, tobacco, tea and coffee can cause varying degrees of addiction or dependence \[[@CR30]--[@CR32]\]. Our findings implied that there might be some concentration effect on dependency or addictive substances, i.e. coffee, tea, alcohol and tobacco, which needs further study.

Conclusions {#Sec11}
===========

In the present study, we provide solid and strong evidence that coffee intake is independently and positively related to pancreatic beta cell function in a large high-risk diabetic Chinese population. Habitual coffee consumption population might have better pancreatic beta cell function in Chinese population.
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